DiggLead source
Anthropic says it has started its own Claude-assisted drug discovery while partnering with six medicine makers, and it says early work has improved lab design, paperwork review and clinical planning.Read original on X
StoryFirst seen
Anthropic starts its own drug discovery work alongside six partners
The move puts the AI lab in direct territory of the drug developers that buy its models.
Archived Updated
Everything it touches
2 names 1 voices 1 source posts
The story’s neighborhood
NAMESVOICESPOSTS
Explore the graph, or choose a connection below.
Follow the evidence
The source posts
This brief comes from Tech Twitter’s edited headlines. The posts below are the sources grouped with the story; statements in them belong to their authors.
Shared connections
Related stories
Anthropic plans to start trading shares next week
A public listing would give investors direct exposure to one of the largest AI model developers.
Anthropic releases Claude Fable 5.2 and Claude Mythos 5.2 models
Both new models are available now, giving developers and businesses fresh options from a leading AI lab.
Anthropic releases Claude Fable 5.2 and Claude Mythos 5.2 models
The models are pitched at harder coding, reasoning, and vision work, which matters to developers and businesses choosing which models to build on.
Anthropic seeks 5 to 10 megawatts of power in older telecom buildings
As a server shortage constrains AI computing, the company is looking at decades-old telecom sites for the power it needs.